参考文献/References:
[1]Vandenhende MA,Buret J,Camou F,et al.Successful daptomycin lock therapy for implantable intra-arterial catheter infection in a patient with liver metastases of colon cancer[J].Diagn Microbiol Infect Dis,2014,78(4):497-498.
[2]德吉,秦金玉,王瑾,等.早期结直肠癌淋巴结转移的危险因素分析及内镜切除指征的探讨[J].中华消化内镜杂志,2015,32(6):367-370.
[3]何科,王晶,徐丽南,等.TACE联合射频消融治疗结肠癌肝转移患者的临床疗效[J].中华肝脏外科手术学电子杂志,2015,4(1):31-34.
[4]胡海峰,年亮,孙晓东,等.帕尼单抗与西妥昔单抗联合伊立替康治疗KRAS野生型转移性结直肠癌患者的疗效分析[J].国际肿瘤学杂志,2015,42(12):907-910.
[5]刘欢,郭茜,齐秀恒.帕尼单抗联合Mfolfox 6方案对老年结直肠癌患者的临床疗效[J].国际老年医学杂志,2017,38(3):112-115.
[6]安永德,郭亚民,范龙鑫,等.手术切除联合射频消融治疗结肠癌肝转移疗效分析[J].实用肝脏病杂志,2016,19(3):327-330.
相似文献/References:
[1]苏周荣,杜东霖,魏正强.左半结肠癌伴梗阻一期切除吻合策略研究[J].医学信息,2018,31(10):51.[doi:10.3969/j.issn.1006-1959.2018.10.016]
SU Zhou-rong,DU Dong-lin,WEI Zheng-qiang.Strategy of One-stage Resection and Anastomosis for Left Colon Cancer with Obstruction[J].Journal of Medical Information,2018,31(01):51.[doi:10.3969/j.issn.1006-1959.2018.10.016]
[2]崔忠泽,何 双,路丽祯,等.基于生物信息学分析筛选结肠癌关键基因[J].医学信息,2022,35(10):1.[doi:10.3969/j.issn.1006-1959.2022.10.001]
CUI Zhong-ze,HE Shuang,LU Li-zhen,et al.Screening Key Genes of Colon Cancer Based on Bioinformatics Analysis[J].Journal of Medical Information,2022,35(01):1.[doi:10.3969/j.issn.1006-1959.2022.10.001]
[3]石 磊,孙新增,李宝山,等.Ⅱ、Ⅲ期结肠癌患者辅助化疗XELOX方案、FOLFOX方案的临床疗效、不良反应及生活质量对比[J].医学信息,2018,31(13):68.[doi:10.3969/j.issn.1006-1959.2018.13.020]
SHI Lei,SUN Xin-zeng,LI Bao-shan,et al.Clinical Efficacy,Adverse Reactions and Quality of Life of Adjuvant Chemotherapy XELOX and FOLFOX in Patients with Stage II and III Colon Cancer[J].Journal of Medical Information,2018,31(01):68.[doi:10.3969/j.issn.1006-1959.2018.13.020]
[4]王 超,范小华,张 力,等.下腔静脉畸形伴腹腔多脏器异位合并结肠癌1例[J].医学信息,2018,31(18):188.[doi:10.3969/j.issn.1006-1959.2018.18.062]
WANG Chao,FAN Xiao-hua,ZHANG Li,et al.a Case of Inferior Vena Cava Malformation Associated with Multiple Abdominal Organ Ectopic Colon Cancer[J].Journal of Medical Information,2018,31(01):188.[doi:10.3969/j.issn.1006-1959.2018.18.062]
[5]吴昭怡,黄金智,张庆余,等.靶向PI3K/AKT/mTOR通路治疗子宫内膜癌的研究现状[J].医学信息,2022,35(12):68.[doi:10.3969/j.issn.1006-1959.2022.12.016]
WU Zhao-yi,HUANG Jin-zhi,ZHANG Qing-yu,et al.Research Status of Targeted PI3K/AKT/mTOR Pathway in the Treatment of Endometrial Carcinoma[J].Journal of Medical Information,2022,35(01):68.[doi:10.3969/j.issn.1006-1959.2022.12.016]
[6]操利超,张核子,余晨笛,等.CLDN11在结肠癌中的预后价值及其作为潜在免疫治疗靶点的研究[J].医学信息,2022,35(14):10.[doi:10.3969/j.issn.1006-1959.2022.14.002]
CAO Li-chao,ZHANG He-zi,YU Chen-di,et al.The Prognostic Value of CLDN11 in Colon Cancer and its Potential Immunotherapy Targets[J].Journal of Medical Information,2022,35(01):10.[doi:10.3969/j.issn.1006-1959.2022.14.002]
[7]苗培田.靶向药物赫赛汀治疗转移性乳腺癌的研究[J].医学信息,2019,32(09):45.[doi:10.3969/j.issn.1006-1959.2019.09.015]
MIAO Pei-tian.Targeted Drug Herceptin in the Treatment of Metastatic Breast Cancer[J].Journal of Medical Information,2019,32(01):45.[doi:10.3969/j.issn.1006-1959.2019.09.015]
[8]葛菁茹,朱静雅,苏日新,等.以肺转移为首发表现的结肠癌预后分析[J].医学信息,2021,34(04):96.[doi:10.3969/j.issn.1006-1959.2021.04.025]
GE Jing-ru,ZHU Jing-ya,SU Ri-xin,et al.Prognostic Analysis of Colon Cancer with Lung Metastasis as the First Manifestation[J].Journal of Medical Information,2021,34(01):96.[doi:10.3969/j.issn.1006-1959.2021.04.025]
[9]韩 猛,薛三宝,倪 丰.CT与MRI术前诊断结肠癌及评价术后复发的价值[J].医学信息,2021,34(21):175.[doi:10.3969/j.issn.1006-1959.2021.21.050]
HAN Meng,XUE San-bao,NI Feng.Value of CT and MRI in Preoperative Diagnosis and Postoperative Recurrence of Colon Cancer[J].Journal of Medical Information,2021,34(01):175.[doi:10.3969/j.issn.1006-1959.2021.21.050]
[10]操利超,巴 颖,卢晓萍,等.基于TCGA和GEO数据库构建结肠癌预后模型[J].医学信息,2021,34(24):27.[doi:10.3969/j.issn.1006-1959.2021.24.006]
CAO Li-chao,BA Ying,LU Xiao-ping,et al.Prognostic Model of Colon Cancer Based on TCGA and GEO Database[J].Journal of Medical Information,2021,34(01):27.[doi:10.3969/j.issn.1006-1959.2021.24.006]